Non-muscle myosin II knockdown improves survival and therapeutic effects of implanted bone marrow-derived mesenchymal stem cells in lipopolysaccharide-induced acute lung injury.

导出 LinkOut

翻译打印收藏纠错

作者： Guosheng,Wu ^[1] ; Fei,Chang ^[2] ; He,Fang ^[1] ; Xingfeng,Zheng ^[1] ; Mingzhu,Zhuang ^[3] ; Xiaobin,Liu ^[1] ; Wenjia,Hou ^[1] ; Long,Xu ^[1] ; Zhengli,Chen ^[1] ; Chenqi,Tang ^[1] ; Yu,Wu ^[4] ; Yu,Sun ^[1] ; Feng,Zhu ^[1]

作者单位： Department of Burn Surgery, Changhai Hospital, Naval Medical University, Shanghai, China. ^[1] Department of Burn and Plastic Surgery, The Affiliated Zhang Jiagang Hospital of Soochow University, Suzhou, China. ^[2] Clinical BioBank, Changhai Hospital, Naval Medical University, Shanghai, China. ^[3] Department of Anesthesiology, Bethune International Peace Hospital, Shijiazhuang, China. ^[4]

关键词 Bone marrow-derived mesenchymal stem cells (BMSCs)acute lung injury (ALI)gene therapy non-muscle myosin II (NM-II)

DOI 10.21037/atm-20-4851

PMID 33708889

发布时间 2022-04-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Annals of translational medicine

2021年9卷3期

262页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Non-muscle myosin II knockdown improves survival and therapeutic effects of implanted bone marrow-derived mesenchymal stem cells in lipopolysaccharide-induced acute lung injury.

Annals of translational medicine

相似文献

Annals of translational medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Non-muscle myosin II knockdown improves survival and therapeutic effects of implanted bone marrow-derived mesenchymal stem cells in lipopolysaccharide-induced acute lung injury.

Annals of translational medicine

相似文献

Annals of translational medicine

相关期刊

检索历史清除